Eleanor Segal | Biopharmaceutical consultant
Consultant

Dr. Eleanor Segal (“Ellie”) is a family physician and geriatrician who was a clinician/teacher for over 20 years before joining the pharmaceutical industry (Syntex) in 1991. A graduate of the University of Michigan Medical School, she is board-certified in family medicine, a Fellow of the American Academy of Family Practice, holds a Certificate of Added Qualifications in Geriatric Medicine and is a Clinical Professor at Stanford University School of Medicine, where she taught several courses, the most notable a course in “Rural Health”. She has written a chapter on common medical problems of geriatric patients for the third edition of “Practical Gerontology” (Carstensen et al, 1996), as well as an article for the Journal of Drug Safety (Risk Management in the Postmarketing Period) along with other articles on medical communication and risk management programs. She is particularly interested in both the issues surrounding communication between physicians and patients and the safety of pharmaceutical agents as used in the aging population. Before moving to Switzerland in 2001 to join Actelion Pharmaceuticals Ltd. as VP and Head of the Global Drug Safety department, which she started, she was Sr. Director of the joint departments of Drug Safety and Pharmacovigilance and Clinical Quality Assurance at Chiron USA, a consultant in pharmacovigilance for Hoffman-La Roche and head of Drug Safety and Quality Management for Sequus Pharmaceuticals. After ten and a half years at Actelion, the last year and a half as the Medical Safety Officer (reporting into the Office of the Chief Medical Officer) and dividing her time between California and Basel, she is now a biopharmaceutical consultant whose home base is northern California.